Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QuestCor QSC -- Ignore unavailable to you. Want to Upgrade?

To: JMood who wrote (89)	6/9/1998 11:26:00 PM
From: roy whitt	Respond to of 120

I was just going over some papers that were heading for the file 13 and I came accoss a cypros paper and well I thought I would use my life time membership to SI. here are the Potential markets for Ceresine and cordox heart surgery/ bypass 900,000 ischemic heart disease 500,000 stroke 500,000 head injury 500,000 sickle cell crisis 150,000 organ transplant 75,000 some of these markets there are no treatments available these numbers come from cypros 97 report if this company can just get 15 % of these markets thats a lot of jack for a small cap company..... comments..... is there any life out there anybody for a dirty joke;;;;;;;